The National Cancer Institute’s “cancer moonshot” tasks researchers with, among advancing other new biotechnologies, delving into immunotherapy and epigenomic analysis.
UC Merced Professor Fabian V. Filipp is doing his part, further developing his work on precision targeting of cancers and...